Modifying PEST for Psoriatic Arthritis Screening

Study of Psoriatic Arthritis

NCT00001420 ·Status: COMPLETED

A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis

NCT03101670 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

NCT03835481 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

NCT03706209 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

NCT01059773 ·Status: COMPLETED ·Phase: PHASE4

Mechanism of Action Study for Psoriasis

NCT00932113 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

NCT00809614 ·Status: COMPLETED ·Phase: PHASE2

A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy

NCT03796858 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice

NCT04053881 ·Status: COMPLETED

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

NCT01925768 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Reliability of PASI Scoring Using Digital-Based Images

NCT05835843 ·Status: COMPLETED

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

NCT01172938 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

NCT02207231 ·Status: COMPLETED ·Phase: PHASE3

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

NCT03731052 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

NCT02173301 ·Status: COMPLETED ·Phase: PHASE2

Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients

NCT05683015 ·Status: RECRUITING ·Phase: PHASE4

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

NCT05701995 ·Status: COMPLETED ·Phase: PHASE4

Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis

NCT01139918 ·Status: COMPLETED

Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice

NCT04517669 ·Status: COMPLETED

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

NCT00534313 ·Status: TERMINATED ·Phase: PHASE2

TIght COntrol of Psoriatic Arthritis

NCT01106079 ·Status: COMPLETED ·Phase: PHASE3

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

NCT01519089 ·Status: COMPLETED ·Phase: PHASE3

A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab

NCT03336281 ·Status: COMPLETED